Home/Filings/4/0001415889-21-000887
4//SEC Filing

CAPEK JOHN M 4

Accession 0001415889-21-000887

CIK 0000001800other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 6:34 PM ET

Size

7.4 KB

Accession

0001415889-21-000887

Insider Transaction Report

Form 4
Period: 2021-02-19
CAPEK JOHN M
Executive Vice President
Transactions
  • Award

    Option (right to buy)

    2021-02-19+71,07071,070 total
    Exercise: $124.04From: 2022-02-19Exp: 2031-02-18Common Shares (71,070 underlying)
  • Award

    Common shares without par value

    2021-02-19+13,865330,665 total
Footnotes (2)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 23,690 on February 19, 2022, 23,690 on February 19, 2023, and 23,690 on February 19, 2024.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001328034

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:34 PM ET
Size
7.4 KB